Atrovent | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Atrovent
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Atrovent

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 9 USDMF, 9 CEP/COS, 1 JDMF, 5 EU WC, 9 KDMF, 14 NDC API, 20 Listed Suppliers, $ API Reference Price

36 API Suppliers
9 USDMF
9 CEP/COS
1 JDMF
5 EU WC
9 KDMF
14 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

38 Drugs in Development

38 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

194 FDF Dossiers, 45 FDA Orange Book, 81 Europe, 18 Canada, 5 Australia, 23 South Africa, 22 Listed Dossiers

194 FDF Dossiers
45 FDA Orange Book
81 Europe
18 Canada
5 Australia
23 South Africa
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.042MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - 0.042MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Kirsch Pharma, 5 Actylis, 1 Finar

2 Kirsch Pharma
5 Actylis
1 Finar

EXCIPIENTS BY APPLICATIONS

6 Parenteral, 2 Solubilizers, 1 Thickeners and Stabilizers

6 Parenteral
2 Solubilizers
1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 16 News #PharmaBuzz

1 Data Compilation #PharmaFlow
16 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 56 Regulatory FDF Prices, 1 Annual Reports

19 US Medicaid Prescriptions
56 Regulatory FDF Prices
1 Annual Reports

MARKET PLACE

11 APIs, 6 FDF Dossiers, 1 EXCIPIENTS

11 APIs
6 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

5 US Patents, 2 Health Canada Patents

5 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 13 Others

4 EDQM
13 Others

$ API Ref.Price (USD/KG) : 4,479 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Boehringer Ingelheim (Canada) Ltd.

filter Patent Reset all filters

2 All

01 12151383

02 12275392

filter Product Reset all filters

2 All

01 1IPRATROPIUM BROMIDE | SALBUTAMOL

02 1Ipratropium Bromide

filter Dosage Reset all filters

2 All

01 1Metered-Dose (Aerosol)

02 1SOLUTION

filter Exp Date Reset all filters

2 All

01 12013-12-06

02 12017-12-16

Vamsi labs Ipratropium Bromide

Product Main Page

01

Boehringer Ingelheim (Canada) Ltd.

Ipratropium Bromide

Pharmaconex

Not Confirmed

Boehringer Ingelheim (Canada) Ltd.

Pharmaconex

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-12-06

Date Granted : 2005-02-08

Ipratropium Bromide

Brand Name : ATROVENT HFA

Patent Number : 2151383

Filing Date : 1993-12-06

Strength per Unit : 20 mcg/actuation

Dosage Form : Metered-Dose (Aerosol)

Human Or VET : Human

Route of Administration : Inhalation

Patent Expiration Date : 2013-12-06

Date Granted : 2005-02-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Boehringer Ingelheim (Canada) Ltd.

IPRATROPIUM BROMIDE, SALBUTAMOL

CPHI Shenzhen

Not Confirmed

Boehringer Ingelheim (Canada) Ltd.

CPHI Shenzhen

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-12-16

Date Granted : 2004-06-29

IPRATROPIUM BROMIDE, SALBUTAMOL

Brand Name : COMBIVENT RESPIMAT

Patent Number : 2275392

Filing Date : 1997-12-16

Strength per Unit : 20 mcg / 100 mcg

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2017-12-16

Date Granted : 2004-06-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!